Effectively treats the root cause
of vaginal atrophy1
You are now leaving novonordisk-hrt.co.uk
You are about to leave the website of novonordisk-hrt.co.uk and view the content of an external website.
Novo Nordisk UK cannot be held responsible for the content of external websites.
You are now leaving novonordisk-hrt.co.uk
You are about to leave the website of novonordisk-hrt.co.uk and go to novonordisk.co.uk
Do you wish to continue?
Effective1,2 convenient and clean3,4
Recommend Vagifem® 10µg:
• Most prescribed local treatment for vaginal atrophy in England5
• Significant improvement in vaginal health versus placebo from 2 weeks2
• Precise, user-friendly dosing delivered where it is needed1,2,6
Vaginal oestrogen is recommended by NICE for the treatment of urogenital atrophy7
References:
1. HRT preparations and equivalent alternatives https://thebms.org.uk/wp-content/uploads/2019/11/HRT-alternatives-04.11.2019.pdf (Accessed 25 June 2020). 2. Kliovance® Summary of Product Characteristics. 3. Kliofem® Summary of Product Characteristics. 4. Novofem® Summary of Product Characteristics. 5. Trisequens® Summary of Product Characteristics.
This is a Novo Nordisk® website intended for UK healthcare professionals
Date of preparation: July 2020 UK20VG00009 Privacy Policy Contact us
This is a Novo Nordisk® website intended for healthcare professionals
Date of preparation: July 2020
UK20VG00009
Privacy Policy Contact us
